Mountain Crest Acquisition Corp. V
Status: Live Deal
U=S+R
R=S/10
| IPO Proceeds, $M | $69.00M |
|---|---|
| IPO Date | Nov 12, 2021 |
| CEO | Suying Liu |
| Left Lead | Chardan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 12 + 3 + 3 + 6 + 12 + 12 |
| IPO Sector |
General
North America and Asia Pacific regions (excluding China, Hong Kong and Macau) |
| IPO Geography | Global |
| Target Company | CUBEBIO |
| Deal Announced | Aug 29, 2024 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Nov 8, 2024 |
MCAG
MCAGU
MCAGR
| Price | $11.00 |
|---|---|
| Last closing price | $11.32 |
| H/L, today | $10.90 / $11.37 |
| H/L, 52-week | $9.90 / $11.40 |
| Volume, today | 26,496 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Mountain Crest Acquisition Corp. V:
- Structure and cap table
- 4 directors & officers
- 41 filings and events
- 1 underwriters
- 1 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Suying Liu | 33 | Chairman, Chief Executive Officer, and Chief Financial Officer |
| Nelson Haight | 56 | Director |
| Todd Milbourn | 52 | Director |
| Wenhua Zhang | 51 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Chardan | BR | 6,000,000 | units |
| 6,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.00 | % |
Sign in to view more advisor data.